Telix Pharmaceuticals Ltd: Telix Completes TLX250-CDx (Zircaix) BLA Submission
Telix Pharmaceuticals Ltd: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
Telix Pharmaceuticals Ltd: Response to ASX Query
Telix Pharmaceuticals Ltd: Telix Submits NDA for New Prostate Cancer Imaging Agent
Telix Pharmaceuticals Ltd: Telix Annual General Meeting - Chairman and CEO Addresses
Telix Pharmaceuticals Ltd: Telix Completes Proof-of-Concept Study for Alpha Therapy
Telix Pharmaceuticals Ltd: Telix has Filed Registration Statement for Proposed US IPO
Telix Pharmaceuticals Ltd: Telix Reports Q1 2024 Financial Performance
Telix Pharmaceuticals Ltd: Telix to File Registration Statement for Proposed US IPO
Telix Pharmaceuticals Ltd: Telix Completes Acquisition of QSAM
Telix Pharmaceuticals Ltd: Pending Release of Shares from Voluntary Escrow
Telix Pharmaceuticals Ltd: Pending Release of Shares from Voluntary Escrow
Telix Pharmaceuticals Ltd: Telix Q1 2024 Revenue and Business Update
Telix Pharmaceuticals Ltd: TLX101-CDx (Pixclara) Granted FDA Fast Track Designation
Telix Pharmaceuticals Ltd: Telix Completes Acquisition of ARTMS
Telix Pharmaceuticals Ltd: Telix Completes Acquisition of IsoTherapeutics
Telix Pharmaceuticals Ltd: Telix General Meeting Chairman and CEO Addresses
Telix Pharmaceuticals Ltd: Appointment of Darren Patti to Group Chief Operating Officer
Telix Pharmaceuticals Ltd: Telix to Acquire ARTMS (Isotope Production Platform)
Telix Pharmaceuticals Ltd: Telix to Acquire IsoTherapeutics (US R&D and Manufacturing)
No Data